Actinomyces sp.

Information

Microbe Identification

Actinomyces sp.

Microbe id: PMDBM2021403
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Actinomyces sp. [29317]
Taxonomy Genus: Actinomyces [1654]
Taxonomy Family: Actinomycetaceae [2049]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Actinomyces sp.

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Actinomyces sp.


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Actinomyces sp. distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Actinomyces sp. in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Actinomyces sp.

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Hemangioma, Cavernous PRJNA629755🔗-2.18714339987147mNGS
Arthritis, Juvenile PRJNA562467🔗-2.9009000370922716S
Diabetes Mellitus, Type 2 PRJNA588353🔗2.7696169107712816S
Diabetes Mellitus, Type 2 PRJNA661673🔗2.8345669960753816S
Diabetes Mellitus, Type 2 PRJDB9608🔗3.3479831758225516S
Liver Cirrhosis, Alcoholic PRJNA690835🔗3.3830747285894516S
Diarrhea PRJNA317326🔗3.4759821536219716S
Dwarfism PRJNA819198🔗3.6731344630343116S
Colorectal Neoplasms PRJEB53415🔗2.7506797486008416S
Colorectal Neoplasms PRJNA1126038🔗2.7776016478359216S
Colorectal Neoplasms PRJDB11845🔗2.8085017317331516S
Colorectal Neoplasms PRJNA986175🔗3.1630719014720116S
Tuberculosis, Gastrointestinal PRJNA743795🔗3.5700487195110816S
Lupus Erythematosus, Systemic PRJEB39044🔗3.8615776854522916S
Growth Disorders PRJEB39484🔗2.0840912788842916S
Colitis, Ulcerative PRJNA993675🔗2.48847186023202mNGS
Carcinoma, Renal Cell PRJNA842560🔗2.3622246861877916S
Carcinoma, Hepatocellular PRJNA932948🔗2.44577640004815mNGS
Carcinoma, Hepatocellular PRJNA872871🔗3.5498104373118816S
Hepatolenticular Degeneration PRJNA1038771🔗3.2042776945994916S
Prediabetic State PRJNA661673🔗3.2297523433453516S
Prostatic Neoplasms PRJNA769284🔗-2.59280399562533mNGS
Emergence Delirium PRJNA797529🔗3.7173293045686116S
Crohn Disease PRJNA993675🔗2.76885138464249mNGS
Crohn Disease PRJNA793776🔗3.00560570669716mNGS
Crohn Disease PRJNA938107🔗3.2452149303584816S
Crohn Disease PRJNA1156939🔗3.33429951724916S
Mastitis PRJNA667141🔗3.4402514753037316S
Polycystic Ovary Syndrome PRJEB38647🔗-2.8797641067869816S
Cholestasis PRJNA478781🔗-3.0615318839245216S
Cholangiocarcinoma PRJNA932948🔗3.16742480826704mNGS
Neuroblastoma PRJEB63351🔗-3.28113472969342mNGS
Graves Ophthalmopathy PRJNA1089481🔗-3.4246311060069916S
Myasthenia Gravis PRJEB41297🔗-3.0201961964817716S
Irritable Bowel Syndrome PRJNA637763🔗2.5808826333803216S
Peutz-Jeghers Syndrome PRJNA545597🔗2.7940244605220816S
IgA Deficiency PRJNA967340🔗-2.124461902422616S
Clostridium Infections PRJNA648321🔗4.16952408543211mNGS
Infant, Low Birth Weight PRJDB10157🔗-2.8845229322072816S
Atrial Fibrillation PRJNA728204🔗4.0307609166900316S
Liver Cirrhosis PRJNA872871🔗2.6069060236536616S
Anti-N-Methyl-D-Aspartate Receptor Encephalitis PRJNA764676🔗4.1710949657058516S
Obesity PRJNA1125836🔗2.2546150311058mNGS
Diabetes Mellitus PRJNA400325🔗3.191718093167316S
HIV Infections PRJDB11949🔗3.0295863089637716S
Autism Spectrum Disorder PRJNA917543🔗2.1235460781990816S
Inflammatory Bowel Diseases PRJNA993675🔗2.35118268327232mNGS
Renal Insufficiency, Chronic PRJEB65297🔗2.12111644736847mNGS
Renal Insufficiency, Chronic PRJNA949558🔗3.1203841826661216S
Renal Insufficiency, Chronic PRJNA659589🔗3.2549190792107616S
Multiple Sclerosis PRJEB53481🔗2.8143260889907416S
COVID-19 PRJNA769052🔗-2.7054024253455916S
COVID-19 PRJNA678695🔗3.1465034266836316S
COVID-19 PRJDB13214🔗3.24817073725775mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Actinomyces sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Actinomyces sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Actinomyces sp.

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Actinomyces sp.


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Actinomyces sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Actinomyces sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Actinomyces sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Actinomyces sp.

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Actinomyces sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Actinomyces sp.


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Actinomyces sp.


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?